Wells Fargo Portfolio holdings
Wells Fargo & Company, founded in 1852 by Henry Wells and William Fargo, is a major American financial institution headquartered in San Francisco, California, known for its extensive retail banking network and historical roots in the American West. Offering a wide range of services—including consumer banking, mortgages, wealth management, and commercial finance—it manages trillions in assets and serves millions of customers through thousands of branches and ATMs across the U.S. Despite its prominence, Wells Fargo faced significant scrutiny following a 2016 scandal involving millions of unauthorized accounts, leading to leadership changes and regulatory penalties, though it has since focused on rebuilding trust and enhancing digital banking capabilities. With a legacy tied to stagecoaches and a modern focus on diversified financial services, Wells Fargo remains a key player in the U.S. banking sector.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.68B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$945M |
| 3 |
American Express
AXP
|
+$595M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$277M |
| 5 |
Vanguard Intermediate-Term Bond ETF
BIV
|
+$274M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.59B |
| 2 |
UnitedHealth
UNH
|
+$795M |
| 3 |
Nike
NKE
|
+$444M |
| 4 |
Target
TGT
|
+$401M |
| 5 |
NVIDIA
NVDA
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.55% |
| 2 | Financials | 8.46% |
| 3 | Industrials | 5.78% |
| 4 | Healthcare | 5.47% |
| 5 | Consumer Discretionary | 5.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2476
Autoliv
ALV
$9.06B
| $4.68M | ﹤0.01% |
41,832
-21,578
| -34% | -$2.11M |
|
2477
Sarepta Therapeutics
SRPT
$1.68B
| $4.67M | ﹤0.01% |
273,056
+124,227
| +83% | +$5.3M |
|
2478
Nuveen Core Plus Impact Fund
NPCT
$280M
| $4.66M | ﹤0.01% |
415,802
+22,361
| +6% | +$233K |
|
2479
ProShares DJ Brookfield Global Infrastructure ETF
TOLZ
$174M
| $4.66M | ﹤0.01% |
86,554
+5,628
| +7% | +$301K |
|
2480
CALL
Vanguard FTSE Emerging Markets ETF
VWO
$123B
| $4.66M | ﹤0.01% |
94,200
-89,100
| -49% | -$4.13M |
|
2481
Avantis Core Fixed Income ETF
AVIG
$1.97B
| $4.66M | ﹤0.01% |
111,883
-93,400
| -45% | -$3.83M |
|
2482
PUT
Bristol-Myers Squibb
BMY
$130B
| $4.65M | ﹤0.01% |
100,500
-4,500
| -4% | -$221K |
|
2483
Klaviyo
KVYO
$5.85B
| $4.63M | ﹤0.01% |
137,999
+130,297
| +1,692% | +$4.13M |
|
2484
Atmus Filtration Technologies
ATMU
$4.43B
| $4.63M | ﹤0.01% |
127,197
-75,390
| -37% | -$2.69M |
|
2485
News Corp Class A
NWSA
$15.7B
| $4.63M | ﹤0.01% |
155,631
+2,483
| +2% | +$68.3K |
|
2486
A10 Networks
ATEN
$2.22B
| $4.61M | ﹤0.01% |
238,446
+56,736
| +31% | +$969K |
|
2487
BILL Holdings
BILL
$4.84B
| $4.61M | ﹤0.01% |
99,638
-47,370
| -32% | -$2.09M |
|
2488
The Bancorp
TBBK
$3B
| $4.6M | ﹤0.01% |
80,765
-41,573
| -34% | -$2.1M |
|
2489
Invesco Biotechnology & Genome ETF
PBE
$288M
| $4.6M | ﹤0.01% |
71,729
-882
| -1% | -$54.6K |
|
2490
Pacer Trendpilot US Bond ETF
PTBD
$85.9M
| $4.59M | ﹤0.01% |
232,421
+12,979
| +6% | +$255K |
|
2491
Gorman-Rupp
GRC
$2.27B
| $4.59M | ﹤0.01% |
124,902
+1,469
| +1% | +$52.8K |
|
2492
ProShares Large Cap Core Plus
CSM
$533M
| $4.59M | ﹤0.01% |
65,075
-1,808
| -3% | -$118K |
|
|
LGI
2493
Lazard Global Total Return & Income Fund
LGI
$237M
| $4.58M | ﹤0.01% |
272,624
+53,342
| +24% | +$833K |
|
2494
Bio-Rad Laboratories Class A
BIO
$9.31B
| $4.57M | ﹤0.01% |
18,954
-4,669
| -20% | -$1.1M |
|
|
LIF
2495
Life360
LIF
$5B
| $4.57M | ﹤0.01% |
70,067
+59,668
| +574% | +$3.07M |
|
2496
IDEAYA Biosciences
IDYA
$3.45B
| $4.56M | ﹤0.01% |
217,134
+47,782
| +28% | +$917K |
|
|
SCHW
2497
CALL
Charles Schwab
SCHW
$188B
| $4.56M | ﹤0.01% |
50,000
| – | – |
|
2498
Intapp
INTA
$2.84B
| $4.56M | ﹤0.01% |
88,249
+16,018
| +22% | +$875K |
|
2499
Donegal Group Class A
DGICA
$729M
| $4.55M | ﹤0.01% |
227,208
+7,349
| +3% | +$142K |
|
2500
Globant
GLOB
$1.66B
| $4.54M | ﹤0.01% |
50,031
+1,097
| +2% | +$117K |
|
Similar funds
Wells Fargo's Q2 2025 Portfolio in Review
As of Q2 2025, Wells Fargo held 7,476 positions worth $483B, up 9.8% from $440B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Wells Fargo's Q2 2025 filing shows 545 new, 3,252 increased, 2,335 reduced and 433 closed positions. Its largest new stake was VanEck Pharmaceutical ETF: 402,987 shares worth $35.4M. The largest sale was Invesco QQQ Trust, an estimated $1.59B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.
- Wells Fargo's largest Q2 2025 buy was VanEck Pharmaceutical ETF: 402,987 shares worth $35.4M.
- Wells Fargo added most to State Street SPDR S&P 500 ETF Trust in Q2 2025, an estimated $3.68B increase.
- Wells Fargo's biggest Q2 2025 reduction was Invesco QQQ Trust, cutting an estimated $1.59B.
- Wells Fargo fully exited Discover Financial Services in Q2 2025, selling an estimated $55.9M.
- Wells Fargo's ten largest holdings make up 20% of its $483B portfolio in Q2 2025.
- Wells Fargo opened 545 new positions and closed 433 in Q2 2025.
- Wells Fargo's portfolio value rose 9.8% quarter-over-quarter to $483B.
Based on Wells Fargo's 13F filing for Q2 2025, filed 14 Aug 2025.